Prototype Drug Unit 3 & 4- Sildenafil (Viagra) Flashcards
Therapeutic classification
Drug for treating impotence
Pharmacologic classification
Phosphodiesterase-5 inhibitor
Therapeutic effects and uses
First drug approved for Erectile Dysfunction. Also used for pulmonary arterial HTN.
Mechanism of action
Relaxes smooth muscle in the corpus cavernosa, allowing increased blood flow into the penis and allowing a harder and longer alsting erection in about 70% of men.
Route
PO
Absorption
Rapid; bioavailability 40%
Distribution
96% protein bound
Metabolism
Hepatic
Excretion
80% feces; 12% renal
Adverse effects
headache, dizziness, flushing, rash, and nasal congestion
Hypotension occurs when taking organic nitrates for angina and can result in MI and sudden cardiac death
Contraindications/Precautions
Contraindications: patients taking organic nitrates, hypersensitivity, severe cardiovascular disease, recent MI, stroke, heart failure, or dysrhythmias, and in the presence of anatomic deformities of the penis. Preexisting visual disturbances
Precautions: renal or hepatic impairment
Drug interactions
Cimetidine, erythomycin, and ketoconazole will increase serum levels. Nitrates is contraindicated and will cause hypotension and even death. Protease inhibitors will cause increased sildenafil levels which leads to toxicity. Rifampin decreases its levels.
Herbal/food interactions
High-fat meals should be avoided because absorption will be decreased. Grapefruit juice increases the plasma concentrations of sildenafil and may cause adverse effects
Pregnancy category
B (Not approved for women)
Nursing responsibilities
1) Complete history and physical examination
2) Complete drug history
3) Baseline vital signs
4) Notify prescriber if patient takes drugs for angina or HTN such as nitroglycerin
5) Monitor liver function tests
6) Monitor for visual adverse effects
7) Monitor for presence of headache, dizziness, flushing, rash, and nasal congestion